Insider Transactions last 24 months for Day One Biopharmaceuticals, Inc.  -  NSDQ: DAWN

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
York Charles N IiCOO and CFO02/17/2026DSDirectCOM6,065$11.60$70,359.46312,025
Vasconcelles MichaelHead of Research and Dev.02/17/2026DSDirectCOM2,728$11.60$31,647.264,397
Dubow AdamGen Counsel & Secretary02/17/2026DSDirectCOM6,395$11.60$74,187.7672,694
Merendino LaurenChief Commercial Officer02/17/2026DSDirectCOM5,814$11.60$67,447.6360,157
Bender JeremyCHIEF EXECUTIVE OFFICER02/17/2026DSDirectCOM15,459$11.60$179,338.31204,603
York Charles N IiCOO and CFO02/15/2026AMDirectCOM7,875$0.00$0.00318,090
York Charles N IiCOO and CFO02/15/2026AMDirectCOM6,625$0.00$0.00310,215
York Charles N IiCOO and CFO02/15/2026AMDirectCOM6,625$0.00$0.00303,590
York Charles N IiCOO and CFO02/15/2026AMDirectCOM2,250$0.00$0.00296,965
Vasconcelles MichaelHead of Research and Dev.02/15/2026AMDirectCOM7,125$0.00$0.007,125
Dubow AdamGen Counsel & Secretary02/15/2026AMDirectCOM4,375$0.00$0.0079,089
Dubow AdamGen Counsel & Secretary02/15/2026AMDirectCOM3,687$0.00$0.0074,714
Dubow AdamGen Counsel & Secretary02/15/2026AMDirectCOM3,688$0.00$0.0071,027
Dubow AdamGen Counsel & Secretary02/15/2026AMDirectCOM1,750$0.00$0.0067,339
Dubow AdamGen Counsel & Secretary02/15/2026AMDirectCOM2,963$0.00$0.0065,589
Merendino LaurenChief Commercial Officer02/15/2026AMDirectCOM4,625$0.00$0.0065,971
Merendino LaurenChief Commercial Officer02/15/2026AMDirectCOM3,687$0.00$0.0061,346
Merendino LaurenChief Commercial Officer02/15/2026AMDirectCOM3,688$0.00$0.0057,659
Merendino LaurenChief Commercial Officer02/15/2026AMDirectCOM3,162$0.00$0.0053,971
Bender JeremyCHIEF EXECUTIVE OFFICER02/15/2026AMDirectCOM14,812$0.00$0.00220,102
Bender JeremyCHIEF EXECUTIVE OFFICER02/15/2026AMDirectCOM11,687$0.00$0.00205,290
Bender JeremyCHIEF EXECUTIVE OFFICER02/15/2026AMDirectCOM11,688$0.00$0.00193,603
Bender JeremyCHIEF EXECUTIVE OFFICER02/15/2026AMDirectCOM4,750$0.00$0.00181,915
Bender JeremyCHIEF EXECUTIVE OFFICER11/25/2025DGIndirectCOM7,225$0.00$0.000
Bender JeremyCHIEF EXECUTIVE OFFICER11/25/2025DGIndirectCOM7,225$0.00$0.007,225
1   2  3  4  5  6  7  Next Last  You are at page 1 of 7 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel